Involvement of the pRb/pl6/cdk4/cycin Dl pathway in the tumorigenesis of sporadic malignant melanomas
1996

Role of pRb/p16/cdk4/cyclin D1 in Melanoma Development

Sample size: 61 publication Evidence: moderate

Author Information

Author(s): GM Maelandsmo, VA Florenes, E Hovig, T OYjord, O Engebraaten, R Holm, A-L Borresen, O Fodstad

Primary Institution: Institute for Cancer Research, The Norwegian Radium Hospital

Hypothesis

The study aims to examine the frequency of gene aberrations involving CDKN2, CDK4, and CCND1 in sporadic metastatic melanomas.

Conclusion

The study found that functional inactivation of pRb through the p16/cdk4/cyclin D1 pathway may be involved in the development or progression of sporadic human melanomas.

Supporting Evidence

  • Homozygous deletions of CDKN2 were found in 11% of tumors and 40% of melanoma cell lines.
  • 59% of metastatic lesions lacked detectable expression of p16 mRNA.
  • 76% of tumors showed high levels of CDK4 mRNA.

Takeaway

Researchers looked at skin cancer samples to see how certain genes were changed, and they found that many had problems with a gene that helps control cell growth.

Methodology

Biopsies from 61 patients with sporadic malignant melanoma were analyzed for gene deletions, mutations, and expression levels.

Limitations

The study may underestimate the frequency of CDKN2 deletions due to contamination with normal cells in tumor biopsies.

Participant Demographics

Patients with sporadic malignant melanoma, including various histological subtypes.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication